Best TRT Services of 2025: Hone Health Expands Nationwide, Making the TRT Easy and Personal

July 8, 2025 10:12 AM

Hone Health At-Home Testosterone Test + Telemedicine TRTHone Health is on a mission to provide the best TRT services. It just announced it's taking its at-home testosterone testing and treatment services nationwide. That means guys anywhere in the U.S. can now access the best TRT services of 2025, all without leaving their house. What if waking up feeling energized was possible again? Picture being able to tackle work, keep up with your kids,...

Read more

Phase 1 Equity Announces It’s Third Practice Addition Of The Year, Bringing On A Multi-Site and Multi-Doctor Orthodontic Practice in Louisiana

July 8, 2025 10:00 AM

Phase 1 Equity, a doctor-owned, doctor-led, and doctor-governed platform for orthodontists and pediatric dentists, is excited to welcome another leading multi-site and multi-doctor orthodontic practice based in Louisiana to its growing network.Recognized for delivering personalized, exceptional care, from advanced 3D imaging to a comprehensive suite of treatments, the practice embodies a culture rooted in innovation, trust, and a steadfast...

Read more

Agape ATP Corporation Signs Strategic Partnerships Agreement to Advance Global Energy and Infrastructure Initiatives

July 8, 2025 9:10 AM

NASDAQ-listed AGAPE ATP Corporation ("ATPC") through its subsidiary ATPC Green Energy Sdn. Bhd., has entered into a strategic partnership agreement ("Strategic Partnership Agreement") with Global Strategic Solutions LLC ("GSS") and BM Trading Services Company Limited ("BMT"), marking a significant step in ATPC's expansion into large-scale energy and infrastructure development across key emerging markets. This trilateral alliance marks a...

Read more

Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institute of Agrarian Innovation (INIA) Supports Research Efforts of Jaguar Health and Filament Health Joint Venture, Magdalena Biosciences, into Potential Mental Health and CNS Indications of Coca

July 8, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that an access and benefit sharing agreement focused on two cultivated species of the coca plant - Erythroxylum coca and Erythroxylum novogranatense - from Peru has been signed between Peru's National Institute of Agrarian Innovation (INIA) and Psilo Scientific, a subsidiary of Filament Health Corp. (OTC:FLHLF) ("Filament"). The access agreement authorizes the research...

Read more

Own the Sneakers from Jordan's First "I'm Back" Victory-His Last Game at the Old Boston Garden

July 8, 2025 8:37 AM

Infinite Auctions, a premier destination for investment-grade sports memorabilia and a subsidiary of Medical Care Technologies Inc. (OTC Pink:MDCE), has officially launched bidding for one of the most historically significant pairs of Michael Jordan game-worn sneakers ever offered at public auction. These iconic shoes were worn during MJ's second game back after his first retirement-March 22, 1995-marking his first victory in his comeback and...

Read more

Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock

July 8, 2025 8:30 AM

Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company revolutionizing orthopedic surgery, today announced the mandatory conversion of all outstanding shares of 8.00% Series D Convertible Cumulative Preferred Stock (the "Series D Preferred Stock") that were issued in connection with the Company's offering that closed on October 1, 2024 (the "Offering"). During the Offering, the Company issued and...

Read more

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

July 8, 2025 8:30 AM

Champions Oncology (NASDAQ:CSBR) a leading translational oncology research organization, today announced the full commercial launch of its radiopharmaceutical services platform. This milestone follows the expansion of the company's radioactive materials license, the completion of the radiochemistry infrastructure, and the successful screening of more than thirty PDX models in collaboration with pharmaceutical and biotech partners.Champions now...

Read more

CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences

July 8, 2025 8:00 AM

CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, is thrilled to announce a transformational leap in its national marketing strategy through integration with Vibe, a cutting-edge self-serve streaming TV advertising platform. This strategic move empowers CBDL to deliver targeted, data-driven campaigns across top-tier streaming platforms including Hulu, ESPN+, Roku, Discovery+, Tubi, and dozens of other premium outlets.As part of...

Read more

Dermata Receives Notice of Grant of Australian Patent for Topical Botulinum Toxin Treatment for Hyperhidrosis

July 8, 2025 8:00 AM

Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata" or the "Company"), a late-stage biotechnology company focusing on the treatment of medical skin diseases and aesthetic applications, today announced the Australian Patent Office has granted its patent application for its DMT410 program for the treatment of hyperhidrosis. The patent, entitled "Compositions for the treatment of skin conditions," (Australian Patent No. 2109284621)...

Read more

Longevity Method Launches to Transform Health and Wellness with Innovative Anti-Aging Solutions

July 8, 2025 7:45 AM

Longevity Method, a pioneering health and wellness company, proudly announces its launch, unveiling a range of anti-aging solutions designed to redefine aging through advanced longevity supplements. Catering to consumers seeking the highest quality, scientifically backed formulations, Longevity Method is committed to delivering products crafted with precision, backed by peer-reviewed research, and supported by a highly qualified scientific...

Read more

Invitation to Presentation of Senzime's Second Quarter 2025 Report

July 8, 2025 7:20 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ.) invites investors, analysts, and media to a webcast presentation of the second quarter report for 2025 on July 18, 13:00 CEST. The report will be published during the morning of the same day.The presentation will be held by Philip Siberg, CEO of Senzime, and after the presentation, there will be a Q&A session moderated by Klas Palin, analyst at Carnegie Investment Bank. The presentation will...

Read more

Boca Recovery Center Announces New Addiction Treatment Center in Springfield, Mass.

July 8, 2025 6:00 AM

In 2023, the State of Massachusetts declared its opioid epidemic to be the state's "greatest public health threat." While there has been some decline in opioid-related overdose since this declaration, the epidemic continues to rage on in certain pockets of the state. Other active forms of substance abuse and addictive disorders in the state only exacerbate the epidemic, moving public officials and other organizations to act urgently.The need for...

Read more

MMJ International Redefines Medical Cannabis with First Plant-Based Drug for a Rare Neurological Disease

July 8, 2025 5:00 AM

Inside a pharmaceutical facility at an undisclosed location, Dr. Elio Mariani, an accomplished pharmaceutical chemist with decades of experience in FDA approved drug formulation, carefully examines a freshly produced batch of MMJ International's soft gelatin capsules. These capsules, each containing a precisely balanced combination of natural THC and CBD extracted from proprietary cannabis strains, represent a historic first: a pharmaceutical...

Read more

Angle PLC Announces Parsortix Enables Study Of Cancer Progression

July 8, 2025 2:00 AM

ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is pleased to announce the publication of a peer-reviewed article in Nature Genetics by Professor Nicola Aceto's team at ETH Zurich, Switzerland. The study utilised the Parsortix® system to investigate the genetic diversity of CTC clusters.Understanding the...

Read more

Sports Injuries Made Every Day a Mortal Struggle Until The Spero Clinic Began Treatment: Kole Jackson's Story

July 7, 2025 7:00 PM

With around 30 million children participating in organized sports in the U.S., almost all of them will experience some kind of injury while playing or practicing. In fact, approximately 3.5 million sports-related injuries occur each year. Most of them are thankfully minor, like cuts and bruises.But not in the case of Ohio teen Kole Jackson. At age 10, Kole suffered two concussions - two minutes apart - while playing football. Little did he know...

Read more

Teva Recognized Among TIME and Statista's 2025 World's Most Sustainable Companies

July 7, 2025 5:30 PM

Teva is proud to be included in the 2025 TIME and Statista list of the World's Most Sustainable Companies, a recognition that underscores our commitment to building a healthier, more sustainable world.Selected from over 5,000 companies worldwide, the top 500 were evaluated on more than 20 key performance indicators including carbon emissions reduction, renewable energy use, DE&I, and ESG transparency. Teva's inclusion reflects our comprehensive...

Read more

Psyence Group Inc. Closes Second Tranche of Non‑Brokered Private Placement for Remaining Proceeds

July 7, 2025 5:00 PM

Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company"), is pleased to announce that it has successfully closed the second tranche ("Tranche 2") of its previously announced non‑brokered private placement (the "Offering"), relying on the accredited investor exemption under section 2.3 of National Instrument 45-106 - Prospectus Exemptions.Under the Offering, the Company issued a total of 6,000,000 common shares at a subscription price of C$0.10...

Read more

MicroGenDX Transforms Infectious Disease Diagnostics With Innovative 24-Hour Testing Technology

July 7, 2025 5:00 PM

MicroGenDX, a national leader in molecular diagnostics, announces the integration of the Illumina MiSeq i100 Plus platform into its lab operations. This advanced DNA sequencing platform enables MicroGenDX to be the only NGS testing provider that delivers test results within 24 hours after sample receipt, empowering providers, hospitals, and patients with faster answers that unlock better care.MicroGenDX combines Next-Gen DNA Sequencing (NGS)...

Read more

Audifort Reviews 2025 (Side Effects and Complaints) Is This Effective Supplement For Tinnitus? A Detailed Analysis

July 7, 2025 12:00 PM

Audifort is a cutting-edge dietary supplement specifically designed to support healthy hearing. Manufactured in a sterile environment, this auditory health supplement contains 20 herbs that work synergistically to address the real reason behind auditory health decline. Consistent intake of Audifort will help the user improve hearing clarity, reduce Tinnitus symptoms, and promote long-term hearing health.The human ear goes through several...

Read more

Resurge Deep Sleep Supplement Reviews 2025 (I Tried It for 90 Days) Here's What Really Happened

July 7, 2025 11:55 AM

Struggling to fall asleep or stay asleep through the night is a challenge many people silently face. I've personally dealt with restless nights for years, trying everything from calming teas to expensive therapies and over-the-counter supplements. Some left me groggy the next day, while others seemed to do nothing at all. For anyone desperate to experience deep, restorative rest, these quick fixes often feel like a letdown.That's what initially...

Read more